Literature DB >> 1376077

CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis.

F Ambrogi1, L Ricciardi, P Nutini, R Vanacore.   

Abstract

Recent research has demonstrated that CD5+ B lymphocytes have an important role in autoimmune and rheumatic diseases. In a case of juvenile rheumatoid arthritis (JRA), we observed the behavior of these cells and other subpopulations of T lymphocytes of peripheral blood before and after therapy with thymopentin (TP5). All the lymphocyte subpopulations returned to normal range, except the CD5+ B cells, where the percentage remained abnormally high (60%). These data suggest that CD5+ B cells can be a useful monitoring index and confirm their important role in the pathogenesis of juvenile rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376077     DOI: 10.1111/j.1749-6632.1992.tb24663.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

2.  Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers.

Authors:  Jing Wang; Wan-Liang Lu; Gong-Wen Liang; Ke-Chun Wu; Chun-Guang Zhang; Xuan Zhang; Jian-Cheng Wang; Hua Zhang; Xue-Qing Wang; Qiang Zhang
Journal:  Peptides       Date:  2005-10-19       Impact factor: 3.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.